Etodolac improves collagen induced rheumatoid arthritis in rats by inhibiting synovial inflammation, fibrosis and hyperplasia

Synovial hyperplasia is the main cause of chronic rheumatoid arthritis (RA), but the mechanism of synovial hyperplasia is still unclear. Etodolac (ETD) is a selective COX-2 inhibitor for relieving pain and stiffness in RA, but the disease modifying effect is still lack of evidence. Proteomics method...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Qin, Xia, Wenkai, Wang, Shenglan, Dai, Guoxin, Jiao, Weimei, Guo, Na, Li, Honghua, Zhang, Guimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607370/
https://www.ncbi.nlm.nih.gov/pubmed/35006449
http://dx.doi.org/10.1186/s43556-021-00052-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607370/
https://www.ncbi.nlm.nih.gov/pubmed/35006449
http://dx.doi.org/10.1186/s43556-021-00052-1

Ejemplares similares